Axsome Stock Is Flying as Fast-Acting Depression Drug Wins FDA Approval
Text size The decision on the drug came a bit less than a year after the FDA’s self-imposed deadline on making a call had passed. Dreamstime The Food and Drug Administration issued a long-awaited approval of a depression drug from Axsome Therapeutics that can take effect within a week, using a different mechanism than traditional … Read more